Scropifav Antivenom Versus Supportive Care Alone in the Treatment of Pediatric Scorpion Envenomation
In pediatric patients with grade ≥2 scorpion envenomation, SCORPIFAV use was associated with reduced need for sedatives, analgesics, and antihypertensive medications. These findings suggest that early administration of SCORPIFAV in the emergency setting may help attenuate the sympathetic response and reduce overall treatment intensity.
Authors
- Gidon Test (ORCID: https://orcid.org/0009-0000-0315-912X)
- Michael Shilo (ORCID: https://orcid.org/0000-0003-1209-3980)
- Miguel Glatstein
- Inbal Kestenbom (ORCID: https://orcid.org/0000-0003-0634-4923)
- Or Kaplan (ORCID: https://orcid.org/0000-0001-8910-5084)
- Dennis Scolnik
- Michael Friger (ORCID: https://orcid.org/0000-0001-7234-6607)
- Michal S. Maimon (ORCID: https://orcid.org/0000-0002-5925-6284)
- Natalya Bilenko (ORCID: https://orcid.org/0000-0003-1694-0833)
- Shaked Bar‐Moshe
- Tal Grupel
Institutions
- Ben-Gurion University of the Negev (IL)
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Sheba Medical Center (IL)
- Soroka Medical Center (IL)
- Hospital for Sick Children (CA)
- Maccabi Healthcare Services (IL)
- Edmond and Lily Safra Children's Hospital (IL)
Publication Details
- Journal
- American Journal of Therapeutics
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1097/mjt.0000000000002046
- Primary Topic
- Venomous Animal Envenomation and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00